Again, Neuropenews asked EFNS/ENS committee members, Panel chairs, Speakers, … which session one should not miss at the upcoming congress in Istanbul, June 2014. You will find the answers below …
Maria Benabdeljil, Delegate Morocco
I will not miss Symposium 4: Alzheimer prevention and uncommon causes of dementia on Monday, 2 June, 8.30-10.30.
In my clinical practice, I am very interested by Alzheimer’s disease and other dementias as I work in a memory centre. My interest lies especially on early-onset dementias, which are relatively frequent in our memory centre series. Uncommon causes of dementia are frequently found in youngest dementia patients and I would like to learn more about these aetiologies.
As the medications against Alzheimer’s disease are still not efficient on the evolution of the disease, an as we do not yet have medication that allow neuroprotection, I am very interested by the current ways of prevention. It is important to have ideas and updates about this subject, in order to counsel our patients and particularly their relatives, who frequently ask about the prevention.
Paul Boon, Co-chair Epilepsy Panel
I will not miss Symposium 8: New therapeutics on the horizon on Tuesday, June 4, 8.30-10.30.
I have a high level of expectation with regard to this session that I hope will provide insights in the innovative future therapies for different neurological diseases from the most prevalent ones such as stroke and epilepsy and others such as MLS and myopathies. I believe this will be very useful for me in dealing with patients with these disorders, interpreting ongoing study results and reviewing work from colleagues relevant to these conditions.
Vitalie Lisnic, Delegate Moldova
I will not miss Symposium 3: Peripheral neuropathies: present and future on Saturday, 31 May, 8.30-10.30.
I will not miss the symposium on peripheral neuropathies, chaired by a well-known specialist in the field of inflammatory neuropathies – professor Pieter A. van Doorn from the Erasmus Medical Center, Rotterdam, The Netherlands. The topic of optimization of the treatment of immune-mediated neuropathies: Guillain-Barré Syndrome, chronic inflammatory demyelinating polyradiculoneuropathy , multifocal motor neuropathy and paraproteinaemic demyelinating neuropathies is of astonishing theoretical and practical value. Within the symposium the last achievements in the field of rapidly developing genetic neuropathies will be presented. It will be great to familiarize with the new insights in the diagnosis and treatment of the most common form of neuropathy – diabetic neuropathy. The issue of amyloid neuropathies is always challenging.
Gustave Moonen, ENS Secretary General
If you feel European,
If you want cutting edge neurology,
If you do not want to miss an historical event: the birth of the European Academy of Neurology, then join us in Istanbul!
I will not miss Symposium 8: New therapeutics on the horizon on Tuesday, 4 June, 8.30-10.30.
Neurology had for long time the reputation of being a contemplative clinical discipline more involved in diagnosis than treatment. This is far from being true due to major progress in neuroscience including clinical research. Do not miss these progresses. Attend symposium 8: New therapeutics on the horizon.
László Sztriha, EAYNT
I will not miss Interactive Session 1: Paroxysmal events on Saturday, 31 May, 11.00-12.30.
I very much look forward to attending the Interactive Sessions that for me have previously been always memorable. The opportunity to listen to and engage in discussions of cases with presenters and fellow colleagues is always an excellent contribution to learning, not to mention the excitement of whether you can get the diagnosis right!
May I also take this opportunity to highlight the Special Session of the EAYNT (European Association of Young Neurologists and Trainees) on Sunday, 1 June, 13.30-14.30, which this year will focus on providing practical advice on how to build a research and/or clinical career in neurology.
